Macular Degeneration Clinical Trials

A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Arizona

Gilbert Arizona 85295

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Gilbert Arizona 85296

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Mesa Arizona 85210

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Peoria Arizona 85381

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona 85014

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

View More ▼

Phoenix Arizona

A clinical research study of X-82, Aflibercept and Placebo

Phoenix Arizona

A clinical trial to evaluate treatments using DE-120 and Aflibercept for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Phoenix Arizona 85014

A clinical trial to evaluate treatments using Lucentis (Treat and extend), Lucentis every 4 weeks and Lucentis every 12 weeks for patients with Neovascular Age Related Macular Degeneration

Phoenix Arizona

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Phoenix Arizona 85020

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Tucson Arizona 85704

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona 85710

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Tucson Arizona

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Tucson Arizona 85750

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

California

Arcadia California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Bakersfield California 93309

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

Bakersfield California

A clinical trial to evaluate treatments using DE-120 and Aflibercept for patients with Age-Related Macular Degeneration

Bakersfield California 93309

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Bakersfield California 93309

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

View More ▼

Beverly Hills California 90211

A clinical research study of Fovista®, Bevacizumab, Ranibizumab and Aflibercept for the treatment of Age-Related Macular Degeneration

Beverly Hills California

A clinical research study of X-82, Aflibercept and Placebo

Beverly Hills California 90211

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Beverly Hills California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Beverly Hills California

A Phase 1 clinical study for patients with Neovascular Age-Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME)

Beverly Hills California 90211

Patients are needed to participate in a clinical research study evaluating APL-2 for the treatment of Neovascular Age-Related Macular Degeneration

Beverly Hills California

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Campbell California 95008

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fresno California 93720

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Fullerton California 92835

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Irvine California 92697

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Irvine California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Irvine California 92697-4375

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

La Jolla California 92093

A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration

La Jolla California 92037

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

La Jolla California 92093-0946

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Los Angeles California 90095

A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration

Los Angeles California 90095

A clinical trial to evaluate treatments using E10030, ranibizumab and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Los Angeles California 90095-7000

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Los Angeles California 90095-7000

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Marietta California 30060

A clinical trial to evaluate treatments using pegaptanib sodium injection for patients with Age-Related Macular Degeneration, Retinal Vein Occlusion or Diabetic Macular Edema

Mountain View California 94040

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Mountain View California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Mountain View California 94040

Patients are needed to participate in a clinical research study evaluating Ranibizumab for the treatment of Recalcitrant Wet Age-related Macular Degeneration

Oceanside California

A clinical trial to evaluate treatments using REGN2176-3 and Intravitreal Aflibercept Injection (IAI) for patients with Neovascular Age-Related Macular Degeneration (AMD)

Palm Desert California 92211

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration

Palo Alto California 94303

Patients are needed to participate in a clinical research study evaluating Lampalizumab and Sham for the treatment of Geographic Atrophy

Redlands California 92374

A clinical trial to evaluate treatments using E10030, bevacizumab or aflibercept and E10030 sham intravitreal injection for patients with Age-Related Macular Degeneration